{"id":"oxydibutanol","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"colenormol","offLabel":[],"synonyms":["oxydibutanol","dihydroxydibutyl ether","colenormol","dyskinebyl"],"timeline":[],"approvals":[],"brandName":"Colenormol","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Colenormol as a key that fits into a lock in the body. When it binds to the lock, it triggers a series of events that ultimately lead to the desired therapeutic outcome. However, without more information on its target and mechanism, it's difficult to provide a more detailed explanation.","oneSentence":"Colenormol is a small molecule compound that works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"Colenormol's exact mechanism of action is unknown, but it is believed to interact with a specific biological target to produce its therapeutic effect. Further research is needed to understand the pharmacological details of Colenormol's action."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/891","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=oxydibutanol","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:11:01.484898","biosimilars":[],"competitors":[],"genericName":"oxydibutanol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005749","UNII":"CR6X2Y7NRR","CHEBI":"CHEBI:134793","RXNORM":"14699","UMLSCUI":"C0047828","DRUGBANK_ID":"DB14079","PUBCHEM_CID":"92141","SNOMEDCT_US":"711297009"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Colenormol, also known as oxydibutanol, is a small molecule compound with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. There is limited information available on its approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to understand the properties and uses of Colenormol. As a result, key safety considerations and mechanism of action are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}